Angela Hernandez
Joined Patexia at Mar 22, 2012
Angela Hernandez
Apr 13, 2012
Next time you decide to head to the tanning salon to get that bronzed glow for beach season, think again. A recent study by the Mayo Clinic reported a significant escalation in skin cancer, especially among people under 40. Young women in particular are the most affected. Although mortality rates... Read More
Angela Hernandez
Apr 12, 2012
Researchers at the Hospital de Mar Research Institute have discovered that the protein LOXL2 has a function within the cell nucleus. A newly-discovered chemical reaction of this protein on histone H3 is involved in gene silencing, which contributes to the progression of breast, larynx, lung and skin tumors. LOXL2’s action... Read More
Angela Hernandez
Apr 12, 2012
A study conducted by UC San Diego biologists has revealed that roundworm intestinal cells, which have a similar structure to those found in humans, internalize bacterial toxins that inactivate certain processes. This activates an immune response, which results in the body creating an immediate attack against the disease-causing microbes. Animal... Read More
Angela Hernandez
Apr 12, 2012
A team at the University of North Carolina introduced the first broad-based test for activation of protein kinases, allowing measurement of the mechanism behind drug-resistant cancer and prediction of successful combination therapies. Kinases are proteins expressed in human tissues that are involved in cell growth, particularly in cancer. About 400... Read More
Angela Hernandez
Apr 12, 2012
Researchers at the California Institute of Technology (Caltech) have outlined the developmental process that ensures certain stem cells will become T cells, immune system cells that help fight pathogens. The researchers observed multipotent hematopoietic precursor cells, which express a variety of genes and differentiate into blood-cell types. They identified all... Read More
Angela Hernandez
Apr 12, 2012
Researchers at the University of Hull have identified biomarkers which could help to predict resistance to chemotherapy in breast cancer patients. Potential biomarkers associated with resistance to chemotherapy drugs include epirubicin and docetaxel. Two high-throughput processes to screen clinical samples of breast tumor tissue were used. Using antibodies, 38 proteins... Read More